NCT03018691View on ClinicalTrials.gov

Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Atopic Dermatitis
Interventions
DRUG

OPA-15406

DRUG

Placebos

Trial Locations (4)

Unknown

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY